PFEPfizer Inc.
Pfizer Inc. (PFE) is a NYSE-listed equity covered by Valdrans. Last close $24.670, +0.53% on the day; -2.04% over 1 week, +1.03% over 4 weeks, -4.33% over 6 months (prices as of 27 Jul 2026).
- Last close (27 Jul 2026)
- $24.670
- Today
- +0.53%
- 1 week
- -2.04%
- 4 weeks
- +1.03%
- 6 months
- -4.33%
- Latest coverage
- PFE Q2 2026 update — filings and holdings
$24.670USD
+0.53% today
1 week-2.04%
4 weeks+1.03%
6 months-4.33%
Coverage of PFE(10)
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
GSK's Bexsero chosen for UK MenB rollout to 1 million students
The NHS will offer GSK's two-dose Bexsero vaccine to around one million Year 13 pupils and under-25s starting university this autumn, following a meningitis B outbreak in Kent.
PFE Q1 2026 update — filings and holdings
US intercepts Iranian missiles over Kuwait as ceasefire talks stall
A tense European session dominated by escalating US-Iran military exchanges, rising oil prices, and divergent equity moves tied to Nvidia's PC chip launch.